Ticker
ICCCCompany Name
IMMUCELL CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 17.14M | 3.85 | $ 4.45M |
3/31/2025 | $ 15.92M | 4.12 | $ 3.87M |
12/31/2024 | $ 15.04M | 3.41 | $ 4.41M |
9/30/2024 | $ 13.89M | 3.11 | $ 4.47M |
6/30/2024 | $ 10.79M | 2.37 | $ 4.56M |
3/31/2024 | $ 11.35M | 2.71 | $ 4.18M |
12/31/2023 | $ 11.47M | 2.73 | $ 4.2M |
9/30/2023 | $ 11.96M | 3.59 | $ 3.33M |
6/30/2023 | $ 10.95M | 2.61 | $ 4.19M |
3/31/2023 | $ 12.25M | 3.19 | $ 3.84M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for IMMUCELL CORP is calculated as follows: AssetsC [ $ 9.94M ] / LiabilitesC [ $ 1.8M ]
(=) Current Ratio [ 5.52 ]
Minimum
Jun 30, 2024
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 3.2K |
---|---|
min | 0 |
max | 6.79 |
average | 2.02 |
median | 1.62 |
std | 1.44 |